-
1
-
-
74549127100
-
-
US Renal Data System. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
-
US Renal Data System, USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009.
-
(2009)
USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States
-
-
-
2
-
-
0031733696
-
Clinical epidemiology of cardiovascular disease in chronic renal disease
-
Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl 3):S112-S119.
-
(1998)
Am J Kidney Dis
, vol.32
, Issue.SUPPL. 3
-
-
Foley, R.N.1
Parfrey, P.S.2
Sarnak, M.J.3
-
3
-
-
0141468244
-
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
-
DOI 10.1161/01.CIR.0000095676.90936.80
-
Sarnak, MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, Mc- Cullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169. (Pubitemid 37337595)
-
(2003)
Circulation
, vol.108
, Issue.17
, pp. 2154-2169
-
-
Sarnak, M.J.1
Levey, A.S.2
Schoolwerth, A.C.3
Coresh, J.4
Culleton, B.5
Hamm, L.L.6
McCullough, P.A.7
Kasiske, B.L.8
Kelepouris, E.9
Klag, M.J.10
Parfrey, P.11
Pfeffer, M.12
Raij, L.13
Spinosa, D.J.14
Wilson, P.W.15
-
4
-
-
23844465424
-
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
-
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 2005; 45: 16-153.
-
(2005)
Am J Kidney Dis
, vol.45
, pp. 16-153
-
-
-
5
-
-
4143100834
-
-
Aggrastat Somerset, NJ, Medicure Pharma Inc
-
Aggrastat: Package Insert. Somerset, NJ, Medicure Pharma Inc, 2008.
-
(2008)
Package Insert
-
-
-
6
-
-
78651070522
-
-
Kenilworth, NJ, Schering-Plough Corporation
-
Integrilin: Package Insert. Kenilworth, NJ, Schering-Plough Corporation, 2009.
-
(2009)
Integrilin: Package Insert
-
-
-
7
-
-
71549119500
-
Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention
-
Tsai TT, Maddox TM, Roe MT, Dai D, Alexander KP, Ho PM, Messenger JC, Nallamothu BK, Peterson ED, Rumsfeld JS: Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA 2009; 302: 2458-2464.
-
(2009)
JAMA
, vol.302
, pp. 2458-2464
-
-
Tsai, T.T.1
Maddox, T.M.2
Roe, M.T.3
Dai, D.4
Kp, A.5
Ho, P.M.6
Messenger, J.C.7
Nallamothu, B.K.8
Peterson, E.D.9
Rumsfeld, J.S.10
-
8
-
-
0242593750
-
Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin
-
Gretler DD: Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin. Clin Ther 2003; 25: 2564-2574.
-
(2003)
Clin Ther
, vol.25
, pp. 2564-2574
-
-
Gretler, D.D.1
-
10
-
-
1842689870
-
Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function
-
Gretler DD, Guerciolini R, Williams PJ: Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function. Clin Ther 2004; 26: 390-398.
-
(2004)
Clin Ther
, vol.26
, pp. 390-398
-
-
Gretler, D.D.1
Guerciolini, R.2
Williams, P.J.3
-
12
-
-
33847361187
-
-
Gambro Polyflux H Dialyzer. Lakewood Gambro
-
Gambro Polyflux H Dialyzer: Package Insert. Lakewood, Gambro, 2006.
-
(2006)
Package Insert
-
-
-
13
-
-
14644410510
-
-
Fresenius F160. Waltham, Fresenius Medical Care
-
Fresenius F160: Package Insert. Waltham, Fresenius Medical Care, 2004.
-
(2004)
Package Insert
-
-
-
14
-
-
0035943030
-
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention
-
Gilchrist IC, O'Shea JC, Kosoglou T, Jennings LK, Lorenz TJ, Kitt MM, Kleiman NS, Talley D, Aguirre F, Davidson C, Runyon J, Tcheng JE: Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention. Circulation 2001; 104: 406-411. (Pubitemid 32678269)
-
(2001)
Circulation
, vol.104
, Issue.4
, pp. 406-411
-
-
Gilchrist, I.C.1
O'Shea, J.C.2
Kosoglou, T.3
Jennings, L.K.4
Lorenz, T.J.5
Kitt, M.M.6
Kleiman, N.S.7
Talley, D.8
Aguirre, F.9
Davidson, C.10
Runyon, J.11
Tcheng, J.E.12
-
15
-
-
0036122627
-
The pharmacodynamics of parenteral glycoprotein IIb/IIIa inhibitors
-
Jennings LK, Jacoski MV, White MM: The pharmacodynamics of parenteral glycoprotein IIb/IIIa inhibitors. J Interv Cardiol 2002; 15: 45-60.
-
(2002)
J Interv Cardiol
, vol.15
, pp. 45-60
-
-
Jennings, L.K.1
Jacoski, M.V.2
White, M.M.3
-
16
-
-
0035943085
-
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: Prospective analysis from PURSUIT
-
Tardiff BE, Jennings LK, Harrington RA, Gretler D, Potthoff RF, Vorchheimer DA, Eisenberg PR, Lincoff AM, Labinaz M, Joseph DM, McDougal MF, Kleiman NS: Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT. Circulation 2001; 104: 399-405.
-
(2001)
Circulation
, vol.104
, pp. 399-405
-
-
Tardiff, B.E.1
Jennings, L.K.2
Harrington, R.A.3
Gretler, D.4
Potthoff, R.F.5
Vorchheimer, D.A.6
Eisenberg, P.R.7
Lincoff, A.M.8
Labinaz, M.9
Joseph, D.M.10
McDougal, M.F.11
Kleiman, N.S.12
-
17
-
-
0035147041
-
Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention
-
Madan M, Berkowitz SD, Christie DJ, Jennings LK, Smit AC, Sigmon KN, Glazer S, Tcheng JE: Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention. Am Heart J 2001; 141: 226-233.
-
(2001)
Am Heart J
, vol.141
, pp. 226-233
-
-
Madan, M.1
Berkowitz, S.D.2
Christie, D.J.3
Jennings, L.K.4
Smit, A.C.5
Sigmon, K.N.6
Glazer, S.7
Tcheng, J.E.8
-
18
-
-
0042165874
-
Platelet glycoprotein IIb/IIIa inhibition with eptifibatide: Prolongation of inhibition of aggregation in acute renal failure and reversal with hemodialysis
-
Sperling RT, Pinto DS, Ho KK, Carrozza JP Jr: Platelet glycoprotein IIb/IIIa inhibition with eptifibatide: prolongation of inhibition of aggregation in acute renal failure and reversal with hemodialysis. Catheter Cardiovasc Interv 2003; 59: 459-462.
-
(2003)
Catheter Cardiovasc Interv
, vol.59
, pp. 459-462
-
-
Sperling, R.T.1
Pinto, D.S.2
Ho, K.K.3
Carrozza Jr., J.P.4
|